Search
for
Sort by
Research 91–120 of 496
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Contents
- Tofacitinib therapy for children with severe alopecia areata
- Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Treatment of scleromyxoedema with hydroxychloroquine
- Immunosuppressive therapy in autoimmune disease — A review
- Dermatologic therapy: December 1987 to December 1988
- Psoriasis of the Scalp
- Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cicatricial alopecia
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Ancient-modern concordance in Ayurvedic plants: some examples.
- Drug repositioning using <i>in silico</i> compound profiling
- Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies
- ANDROGRAPHOLIDE LOADED TOPICAL NANOCARRIERS FOR MANAGEMENT OF PSORIASIS: A SAFE AND EFFECTIVE APPROACH
- Extraction of Polyphenol Compounds from Herbal Plant Stems of Kalimantan Using Ethanol Solvent
- Chemical Constituents & Therapeutic Uses of Eclipta Prostrata Linn
- Recommendations on trichological treatments during COVID-19 pandemic
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 12. Cancer
- Dermatological adverse events with taxane chemotherapy
- Drug-Induced Skin, Nail and Hair Disorders
- Update on the dermatologic use of systemic glucocorticosteroids
- Nanocarrier Systems for Transdermal Drug Delivery
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases